Neonatal Hypoglycemia: Why Newborns Get Low Blood Sugar?

The nurse told you your baby’s blood sugar is low. Now, there is talk of a glucose drip and NICU. You are exhausted, frightened, and wondering how this happened to a healthy, full-term baby who seemed completely fine.

Low blood sugar in newborns, called neonatal hypoglycemia, is one of the most common metabolic conditions in the first hours of life, occurring in healthy babies as well as at-risk ones.

Most cases resolve quickly with simple treatment. A small number require more intensive management. Knowing the difference begins with understanding why it happens in the first place.

For families seeking expert guidance on low blood sugar in newborn treatment in Secunderabad, Shenoy Hospitals provides comprehensive newborn metabolic monitoring and treatment with dedicated neonatal care for every risk level.

Key Takeaways:

• Why blood sugar falls in every newborn after birth, and where the normal line is
• Which babies are at highest risk and why
• Why most neonatal hypoglycemia produces no symptoms, and why that matters
• How it is treated, including a new first-line treatment most parents don’t know about
• Whether low blood sugar in a newborn can cause brain damage, and what the evidence says

What Is Neonatal Hypoglycemia and How Is It Different From Low Blood Sugar in Adults?

Neonatal hypoglycemia is abnormally low blood glucose (sugar) in a newborn baby defined as a blood glucose level below 2.6 mmol/L (47 mg/dL) in the first days of life.

This matters because glucose is the brain’s primary fuel. Without adequate glucose, the newborn brain cannot function properly, and in prolonged or severe cases, this inadequate fuel supply can cause lasting injury.

• The Normal Newborn Glucose Transition

Every newborn experiences a physiological fall in blood glucose in the first 1–2 hours after birth. This is expected and normal.

In the womb the placenta delivers glucose from the mother’s blood continuously. 

At birth, that supply cuts off instantly. The baby must now maintain its own blood glucose using stored glycogen (sugar stored in the liver) and by activating fat and amino acid metabolism.

In a well-prepared, well-fed newborn, this transition happens smoothly. In certain babies, it does not, and glucose falls below the threshold where the brain is adequately supported.

• Where the Line Is Drawn?

Blood glucose below 2.6 mmol/L in the first 48 hours of life is the widely used clinical threshold for intervention, supported by the British Association of Perinatal Medicine, the American Academy of Pediatrics, and the Australasian guidelines.

This is not an absolute biological threshold; it is a clinical decision point where the risk of ongoing low glucose outweighs the risk of treatment.

Some babies tolerate glucose levels slightly below this without apparent harm; others develop symptoms above it. This is why clinical assessment always accompanies the number.

Why Do Even Healthy Full-Term Babies Develop Low Blood Sugar?

This is the question most parents didn’t think to ask before delivery, and the answer is in the biology of birth itself.

• The Glycogen Store Depletion Mechanism

Glycogen is glucose stored in the liver and muscle accumulated during the final weeks of pregnancy. It serves as the newborn’s fuel reserve during the transition to independent feeding.

A baby born at term with good glycogen stores who feeds early and frequently will typically transition without significant hypoglycemia. But glycogen stores are finite; they last only a few hours under normal conditions and are depleted faster when the baby is cold, stressed, or feeding is delayed.

Any factor that increases glucose consumption or reduces glucose supply in the first hours of life tips the balance toward hypoglycemia, even in an outwardly healthy baby.

• The Delayed First Feed Connection

Feeding in the first hour after birth is the single most effective prevention for neonatal hypoglycemia. 

The first feed, whether colostrum, formula, or glucose supplementation, replaces the glucose the baby’s liver was supplying and bridges the gap until feeding is established.

A baby who does not feed in the first hour or who feeds inadequately exhausts glycogen stores without replacement. Even colostrum volumes of 2–5 ml make a clinically meaningful difference to blood glucose stability in a term baby.

If you are navigating latch challenges or are unsure whether your baby is transferring adequate volume, our guide on breastfeeding tips every new mother should know covers positioning, latch assessment, and supply-building strategies that directly support this critical early feeding window. 

This is one of the strongest clinical arguments for immediate skin-to-skin contact and early breastfeeding initiation; they are not simply bonding practices, they are metabolic interventions.

• Why Some Full-Term Babies Are More Vulnerable?

Certain full-term babies have reduced glycogen stores or impaired glucose regulation through no visible fault.

Large babies, those born above the 90th percentile for weight, often have disproportionate body composition with higher muscle mass and greater glucose demand. 

Small babies, those below the 10th percentile, have inadequate glycogen stores because poor placental nutrition limited the fetal fat and sugar accumulation of the third trimester.

Both extremes of birth weight carry increased hypoglycemia risk for opposite physiological reasons.

Which Babies Are at Highest Risk?

• Babies of Diabetic Mothers: The Most Common High-Risk Group

This is the group where the hypoglycemia mechanism is most clearly understood, and it involves a hormonal process that competitor content rarely explains.

During pregnancy high maternal blood glucose crosses the placenta and stimulates the fetal pancreas to produce elevated levels of insulin  the hormone that moves glucose from the blood into cells.

At birth, the maternal glucose supply stops. But the fetal pancreas, conditioned to producing high insulin, continues to do so. The result is a baby with normal or low glucose levels being actively driven lower by their own excessive insulin production.

This is called hyperinsulinism, and it is the reason babies of diabetic mothers require blood glucose monitoring for at least 12–24 hours after birth, regardless of how well they appear.

• Large for Gestational Age (LGA) and Small for Gestational Age (SGA) Babies

As described above, both LGA babies (high glucose demand often with underlying hyperinsulinism) and SGA babies (poor glycogen reserves from placental insufficiency) require monitoring.

SGA babies, particularly those with evidence of intrauterine growth restriction, are at particular risk of symptomatic hypoglycemia because they have virtually no glycogen buffer to draw on when feeding is delayed.

• Premature and Late Preterm Infants

Premature babies miss the final weeks of glycogen accumulation and have immature counter-regulatory hormones—the hormones that raise blood sugar in response to low glucose. Their metabolic response is blunted, making hypoglycemia more likely and recovery slower.

Late preterm babies (34–36 weeks) are particularly vulnerable because they appear well but have the metabolic profile of a premature baby—a combination that leads to underestimation of their hypoglycemia risk.

• Stressed Babies: Cold, Asphyxiated, or Infected

Cold stress, birth asphyxia, and infection all dramatically increase glucose consumption as the body directs energy to manage the physiological challenge.

A baby who is hypothermic burns glucose to generate heat. This is the temperature-glucose connection that competitor content universally ignores: keeping a newborn warm is not just comfort; it is a direct metabolic intervention that reduces hypoglycemia risk.

Skin-to-skin contact maintains temperature and supports glucose simultaneously.

What Are the Symptoms of Low Blood Sugar in a Newborn?

• The Asymptomatic Majority The Most Important Clinical Fact

This is the single most important thing parents need to understand about neonatal hypoglycemia: the majority of cases produce no obvious symptoms.

A baby can have a blood glucose of 1.8 mmol/L—well below the treatment threshold—and look completely peaceful, pink, and normal.

Relying on symptom observation alone to detect neonatal hypoglycemia will miss most cases. This is exactly why at-risk babies are screened with blood tests regardless of appearance.

• Neurological Symptoms: The Brain’s Distress Signals

When symptoms do occur, they reflect the brain’s inadequate glucose supply.

Jitteriness, a fine rhythmic tremor of the limbs, is the most common neurological symptom. It differs from a normal newborn startle response in that it is not triggered by noise or touch and does not resolve with gentle restraint.

Seizures represent significant neurological glucose deprivation and require immediate treatment. They appear as rhythmic limb movements, eye deviation, lip smacking, or sudden stiffening.

Irritability, a high-pitched cry, and excessive sleepiness are softer neurological indicators that warrant glucose measurement.

• The Deceptively Quiet Baby

Excessive sleepiness or hypotonia (floppiness) in a newborn is not a reassuring sign; it is a warning sign. A baby who cannot be roused for feeds, who feeds for only seconds before falling deeply asleep, or who feels limp when held may be experiencing glucose-related neurological depression.

Do not interpret a very quiet, still newborn as a settled baby without checking feeding adequacy and glucose.

How Is Neonatal Hypoglycemia Diagnosed?

• Bedside Glucose Testing  The First Check

A heel prick blood sample provides a glucose reading within 30–60 seconds using a bedside glucometer. This is the screening tool: rapid, accessible, and sufficient to identify babies needing treatment.

Bedside readings have a margin of error of approximately 10–15% compared to laboratory values. 

A bedside reading below 2.6 mmol/L should be confirmed with a laboratory sample before non-urgent management decisions are made, but treatment should not be delayed awaiting laboratory confirmation if the baby is symptomatic or the bedside value is critically low.

• Screening Protocols: Who Gets Tested and When

At-risk babies—including those born to diabetic mothers, premature babies, LGA and SGA babies, and babies with birth asphyxia—are screened at 30 minutes to 1 hour of age, before the first expected nadir (low point) in transitional hypoglycemia.

Screening continues every 30 minutes to 3 hours, depending on the risk category and previous values, until the baby has demonstrated stable glucose levels across at least three consecutive feeds.

• The Critical Value Requiring Immediate Action

A blood glucose below 1.5 mmol/L (27 mg/dL), or any symptomatic hypoglycemia regardless of value, requires immediate treatment without waiting for laboratory confirmation.

Below 1.5 mmol/L, brain fuel deprivation is severe enough to cause injury within minutes in a symptomatic baby. This is the number that triggers emergency intravenous treatment.

How Is Neonatal Hypoglycemia Treated?

• Early Feeding: The First-Line Intervention

For a baby with mild hypoglycemia (2.0–2.6 mmol/L) who is alert and able to feed, the first intervention is immediate feeding (breast, expressed milk, or formula) followed by a glucose recheck in 30 minutes.

Frequent feeding every 1–2 hours in the first 12–24 hours is both treatment and prevention. Ensuring the baby is latching effectively and transferring adequate volume is, therefore, a clinical priority, not just a breastfeeding support issue.

• Dextrose Gel The Treatment Most Parents Never Hear About

This is the clinical advance that competitor content almost universally misses.

40% dextrose gel—a concentrated glucose gel applied to the inside of the baby’s cheek and gently massaged into the mucosa is now recommended as first-line treatment for mild-to-moderate neonatal hypoglycemia in term and late preterm babies by the British Association of Perinatal Medicine, Pediatrix guidelines, and New Zealand national protocols.

A landmark study published in The Lancet (Harris et al., 2013) found that dextrose gel was more effective than feeding alone in treating neonatal hypoglycemia, reduced NICU admissions by 30%, and supported continuation of breastfeeding.

The gel is absorbed through the oral mucosa rapidly, raising blood glucose within 20–30 minutes. It can be given before and alongside feeding. 

It is simple, safe, and represents a significant improvement in how mild hypoglycemia is managed; yet, most parents have never heard of it.

• Intravenous Dextrose  When Oral Treatment Is Not Enough

When a baby cannot feed adequately, has symptomatic hypoglycemia, or has a glucose level below 1.5 mmol/L, intravenous dextrose is required.

An IV line is placed, and a dextrose infusion is started at a standard rate to bring glucose into the safe range quickly. The rate is then adjusted based on repeat glucose measurements.

IV dextrose in the neonatal unit does not mean the baby cannot return to breastfeeding. Many babies receive IV dextrose alongside breastfeeds, with the infusion weaned as feeding volumes and glucose stability increase.

• Persistent Hypoglycemia: When To Investigate Further

Most neonatal hypoglycemia resolves within 24–48 hours as feeding establishes and the transitional period ends.

Hypoglycemia that persists beyond 48–72 hours, requires unusually high glucose infusion rates, or recurs repeatedly despite adequate feeding requires investigation for an underlying cause, including congenital hyperinsulinism (a rare condition of persistent insulin overproduction), metabolic disorders, or hormonal deficiencies.

This distinction transient vs persistent hypoglycemia—is clinically critical and never made in competitor patient content. Persistent hypoglycemia is managed by a paediatric endocrinologist and follows a different diagnostic and treatment pathway.

If your baby has been diagnosed with low blood sugar after birth and you are in Secunderabad, the neonatal team at Shenoy Hospitals provides expert assessment, including glucose monitoring, dextrose gel treatment, IV management where needed, and investigation of persistent cases. Our Paediatrics and Neonatal Care department manages every level of neonatal hypoglycemia from transient transitional cases to persistent hyperinsulinism requiring specialist investigation. 

Can Neonatal Hypoglycemia Cause Brain Damage?

This is the question every parent asks, and it deserves a direct evidence-based answer.

• The Mechanism of Glucose-Related Brain Injury

The brain depends almost exclusively on glucose for energy. When glucose falls below a critical level for long enough, neurons (brain cells) cannot sustain normal function, and in severe or prolonged cases, they begin to die.

The brain regions most vulnerable to glucose deprivation include the occipital cortex (processing vision) and the hippocampus (involved in memory), explaining why the long-term consequences of severe neonatal hypoglycemia can include visual impairment and learning difficulties.

• What Severity and Duration Determine?

A single brief episode of mild hypoglycemia that is promptly treated does not cause brain injury in the vast majority of cases. The clinical concern is with:

Severe hypoglycemia (below 1.5 mmol/L), symptomatic episodes (especially seizures), prolonged duration without treatment, and recurrent episodes across multiple days.

The babies who sustain neurological injury from neonatal hypoglycemia are those whose low glucose was undetected, untreated, or undertreated—not those identified through appropriate screening and managed promptly.

• Long-Term Outcomes With Early Treatment

Research published in Pediatrics and the New England Journal of Medicine confirms that treated neonatal hypoglycemia in term babies—identified through screening and managed appropriately—does not produce measurable neurodevelopmental differences at 2 and 4.5 years of age compared to matched controls.

Early detection and treatment is the variables that determine outcome. This is why screening at-risk babies, even when they appear well, is not excessive caution. It is the intervention that prevents the sequelae parents are rightly afraid of.

How Can Parents Help Prevent Neonatal Hypoglycemia?

• Skin-to-Skin and Early First Feed

The two most effective parent-driven prevention strategies are skin-to-skin contact from birth and feeding within the first hour.

Skin-to-skin maintains the baby’s temperature, reducing glucose consumed in heat generation. It stimulates feeding behavior through proximity to the breast, and it supports the hormonal environment that stabilizes glucose.

For at-risk babies, the first feed should happen within 30–60 minutes of birth and should be supported by a midwife or lactation consultant if needed.

• Feeding Frequency in the First 24 Hours

Feed every 1–2 hours in the first 24 hours for any at-risk baby; do not wait for hunger cues if the baby is sleepy. A baby who has been asleep for 3 hours since the last feed has had a 3-hour fast, which, for a baby with limited glycogen reserves, is clinically relevant. 

Feeding adequacy and weight gain are closely connected in these early days; our guide on why newborns lose weight after birth explains what weight trajectories are expected versus concerning, and why feeding frequency is the primary lever parents control. 

Waking a sleepy, at-risk baby to feed is not disrupting their rest; it is preventing hypoglycemia.

• Keeping the Baby Warm

A cold baby burns glucose to generate heat. Maintain room temperature between 25–28°C for a newborn, dress appropriately for the environment, and avoid unnecessary exposure of the skin during examinations.

Hypothermia and hypoglycemia in newborns are interlinked; addressing one helps the other. Skin-to-skin contact remains the most effective way to maintain temperature while simultaneously supporting feeding and glucose.

Final Thoughts

Neonatal hypoglycemia is common, well understood, and, when identified through appropriate screening and treated promptly, almost always resolves without lasting consequences.

The babies at risk are known in advance. The testing is quick and minimally invasive. The treatments are effective, simple, and increasingly baby-friendly,  from early feeding and skin-to-skin to dextrose gel and when necessary, IV dextrose.

The key is not to be alarmed by the diagnosis; it is to understand why the monitoring and treatment exist and to engage with them fully. 

A screened treated baby with transient hypoglycemia has an excellent prognosis. The danger lies in the cases that slip through unseen, asymptomatic, and untreated.

Trust the protocol. Ensure early feeding. Keep your baby warm. And ask your care team to explain every glucose result in plain language.

FAQs

Can low blood sugar in a newborn cause brain damage?

Severe, prolonged, or repeatedly untreated neonatal hypoglycemia can cause brain injury, but a single mild episode identified through screening and treated promptly does not cause lasting neurological harm in the vast majority of cases. Research confirms that appropriately treated neonatal hypoglycemia in term babies produces no measurable neurodevelopmental differences at follow-up. Early detection through screening—not symptom observation—is what determines outcome.

How often should a newborn’s blood sugar be checked?

The frequency depends on the baby’s risk category. High-risk babies—those born to diabetic mothers, premature babies, large or small for gestational age, or those with birth stress—are screened at 30–60 minutes of age, then every 1–3 hours for the first 12–24 hours or until stable across multiple readings. Low-risk babies do not require routine glucose screening. Ask your paediatric team which protocol applies to your baby.

Does breastfeeding prevent neonatal hypoglycemia? 

Breastfeeding within the first hour of birth significantly reduces neonatal hypoglycemia risk by providing colostrum that replaces the glucose the baby’s liver was supplying and triggers the hormonal cascade that stabilises blood sugar. However, breastfeeding alone does not fully prevent hypoglycemia in high-risk babies, such as those born to diabetic mothers or with growth restriction; these babies require blood glucose monitoring regardless of feeding method.

How is neonatal hypoglycemia treated without an IV drip? 

For mild to moderate hypoglycemia, two treatments can be used before IV dextrose is needed: early frequent feeding (breast, expressed milk, or formula) and dextrose gel—a 40% glucose gel applied to the inside of the cheek that raises blood glucose through mucosal absorption. Dextrose gel is now recommended as first-line treatment by several national guidelines and reduces the need for IV treatment and NICU admission. Ask your neonatal team whether dextrose gel is part of their protocol.

Can a baby with low blood sugar still breastfeed? 

Yes, and breastfeeding is actively encouraged alongside treatment for neonatal hypoglycemia. Even babies on IV dextrose can and should breastfeed as their feeding ability allows. The IV infusion is weaned as oral feeding volumes increase and glucose stabilises. Stopping breastfeeding for hypoglycemia treatment is not necessary and is not recommended; breastmilk and breastfeeding are part of the treatment, not a contraindication to it.